Clinical Drug Experience Knowledgebase

Dermatomycoses

Tinea

Tinea Pedis

Adenocarcinoma (Phase 2)

Amyloidosis (Phase 3)

Autism Spectrum Disorder (Phase 2)

Autistic Disorder (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Merkel Cell (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Small Cell (Phase 1)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Crohn Disease (Phase 2)

Cytomegalovirus Infections (Phase 2)

Endometrial Neoplasms (Phase 1)

Glioblastoma (Phase 1)

Glioma (Phase 1)

Immunoglobulin Light-chain Amyloidosis (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Lung Diseases (Phase 2)

Lung Neoplasms (Phase 2)

Lymphadenopathy (Phase 2)

Lymphoma (Phase 2)

Mesothelioma (Phase 1)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Neoplasms (Phase 2)

Pain, Postoperative (Phase 3)

Paraproteinemias (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Psoriasis (Phase 2)

Ulcer (Phase 2)